Access to cancer genomics and precision oncology remains profoundly unequal worldwide, limiting benefits for millions of patients and hindering research progress.
- 10 cites
Moving in The Lancet Oncology, Gastroenterology, Cancer Cell, Gut, Nature Medicine, New England Journal of Medicine.
Rebuilt
Nothing in this area has moved yet this week.
Newest first · last 60 days
Access to cancer genomics and precision oncology remains profoundly unequal worldwide, limiting benefits for millions of patients and hindering research progress.
Global 5-year breast cancer survival rates from 2017-2021 ranged from 39.1% in Africa to 88.5% in the Americas, highlighting significant regional disparities.
Journals this month
Moving areas, week to 3 Oct 2026